New Delhi: Mylab Discovery Solutions on Wednesday announced that its ‘Pathocatch’ covid-19 antigen rapid testing kit has received a commercial approval from the Indian Council of Medical Research, making it the first Indian firm to get the nod.“After bringing an affordable RT-PCR test to reduce dependence on foreign kits, we launched Compact XL to accelerate COVID-19 testing.
Now, with the approval for an antigen testing kit, we will cover whole spectrum of COVID-19 testing and leave no stone unturned to fight this pandemic," Mylab managing director Hasmukh Rawal was quoted as saying in a statement.Mylabs said its antigen test is priced at ₹450 per unit.